New Jazz cancer drug approval could drive blockbuster sales

Reports

3

Domains carrying it

2

First reported

25 August 2026

Latest report

31 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 25 August 2026Jazz's HER2 bispecific Ziihera gains FDA approval to change practice in stomach cancerfiercepharma.com
2. 31 August 2026Jazz's Ziihera secures 2nd survival win to solidify its HER2-positive stomach cancer statusfiercepharma.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA Approves Ziihera Regimens in First-Line HER2+ Advanced GEA14 reports · 10 domains · 2 September 2026
• U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...12 reports · 12 domains · 17 August 2026
• FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer59 reports · 51 domains · 5 September 2026
• FDA Grants Accelerated Approval to a New Breast Cancer Treatment8 reports · 7 domains · 5 September 2026
• AstraZeneca's Breast Cancer Pill Gets Approval From the FDA5 reports · 5 domains · 5 September 2026
• FDA Grants Fast Track Designation to BI-1808 Plus Pembrolizumab in Ovarian Cancer2 reports · 2 domains · 7 August 2026

◆ Share

◆ Evidence

3 reports · 2 domains

• Jazz's Ziihera secures 2nd survival win to solidify its HER2-positive stomach cancer statusfiercepharma.com · 31 August 2026
• New Jazz cancer drug approval could drive blockbuster salesbiopharmadive.com · 25 August 2026
• Jazz's HER2 bispecific Ziihera gains FDA approval to change practice in stomach cancerfiercepharma.com · 25 August 2026